Pierce Protease and Phosphatase Inhibitor Mini Tablets,EDTA-free
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0451118
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $242.11
About this award
Life Technologies Corporation has been awarded a contract by the University of Virginia to supply Pierce Protease and Phosphatase Inhibitor Mini Tablets, EDTA-free, with an award date of June 20, 2026. The contract, identified as A207_PO-0451118, is valued at $242.11 and involves the delivery of one unit to Keena Seagle Thomas. The unit price for the protease and phosphatase inhibitor tablets is $242.11 per unit.
The award was executed in Virginia under the University of Virginia's contracting authority. Based on the contract documentation, the cumulative contract value totals $242.11 for the single line item purchase. No specific period of performance or place of performance beyond the identified recipient is documented in the available contract materials.
Line items
| Item | Total |
|---|---|
| Pierce Protease and Phosphatase Inhibitor Mini Tablets,EDTA-free | $242.11 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0451118?
Contract A207_PO-0451118 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on June 20, 2026.
How much is contract A207_PO-0451118 worth?
Its cumulative value is $242.11.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award